Poon Christine A
- SEC CIK
- 0001189014
In the past year, 1 open-market sale filing worth $4.25M and no purchases.
Current role at each company
- PFH Prudential Financial IncDirectoras of Sep 14, 2026
- NBIX Neurocrine Biosciences IncDirectoras of May 29, 2026
- REGN Regeneron Pharmaceuticals, Inc.Directoras of Jan 6, 2026
- SHW Sherwin Williams CoDirectoras of Apr 7, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $4.25M
- 1 filing
- Net
- −$4.25M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Poon Christine A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
REGN Regeneron Pharmaceuticals, Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 31, 2025 (view filing) | Oct 29 | 2 days | Poon Christine ADirector | SSale | −6.50K | $654.27 | −$4.25M | −73.4%2.35K after | 6 lots |
| Aug 19, 2024 (view filing) | Aug 15 | 4 days | Poon Christine ADirector | SSale | −10.8K | $1,158.17 | −$12.6M | −83.3%2.17K after | 7 lots |
| Aug 25, 2023 (view filing) | Aug 23 | 2 days | Poon Christine ADirector | SSale | −12.3K | $839.97 | −$10.3M | −85.8%2.04K after | 5 lots |
| Aug 11, 2022 (view filing) | Aug 9 | 2 days | Poon Christine ADirector | SSale | −15.0K | $620.91 | −$9.31M | −88.9%1.87K after | 2 lots |
| Aug 31, 2021 (view filing) | Aug 27 | 4 days | Poon Christine ADirector | SSale | −15.0K | $668.09 | −$10.0M | −89.9%1.68K after | 11 lots |